Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-75
SponsorMaria Cecilia Hospital

About this trial

Cardiovascular diseases represent one of the leading causes of morbidity and mortality worldwide. Prevention in patients at cardiovascular risk is essential to reduce the incidence of cardiovascular events and slow the progression of risk.

This study aims to evaluate the effectiveness and feasibility of a cardiovascular prevention pathway delivered remotely through a digital application, comparing it with a traditional in-person care pathway.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 40 and 75 years

hypertension

hyperglycaemia

type 2 diabetes not requiring insulin therapy

Disqualifiers

previous myocardial infarction

stroke

transient ischemic attack

coronary artery diseas

Trial design

Design model

Parallel

Treatments tested in this trial

  • Recommendations to the patient.

    Other intervention

    Recommendations to the patient

Treatment groups

144 Participants
are divided into 2 treatment groups
Group A: Digital technologyExperimental treatment 1 intervention
Group B: on siteOther 1 intervention

Trial outcomes

Primary outcomes

1

Blood pressure

Systolic and diastolic in millimeters of mercury

Time frame
12 months
2

number of cigarettes

Time frame
24 months

Secondary outcomes

1

body weigh

Time frame
24 months
2

number of daily steps

Time frame
24 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.